Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimized Treatment and Regression of HBV-induced Compensated Liver Cirrhosis

NCT01943617 is registered in ClinicalTrials.gov with Beijing Friendship Hospital as lead sponsor.

NCT NCT01943617
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01943617 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimized Treatment and Regression of HBV-induced Compensated Liver Cirrhosis
Lead sponsor
Beijing Friendship Hospital
Phase
Phase 4
Overall status
Completed
Start date
June 30, 2013
Completion date
December 31, 2016
Enrollment
606 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

liver cirrhosis